• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Waters Corporation Announces CFO Transition

    12/3/20 6:59:00 AM ET
    $WAT
    $TXT
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Aerospace
    Industrials
    Get the next $WAT alert in real time by email

    MILFORD, Mass.--(BUSINESS WIRE)--Waters Corporation (NYSE:WAT) today announced that Sherry Buck will step down as Chief Financial Officer, effective December 31, 2020, in order to pursue another opportunity at a privately held company. Upon her departure, Michael F. Silveira, Vice President and Corporate Controller of Waters, will assume the role of interim Chief Financial Officer. Ms. Buck will work alongside Mr. Silveira in order to facilitate a smooth transition. Waters has been actively working with a leading search firm to identify a permanent CFO, and the process is advancing well with several strong internal and external candidates.

    “On behalf of the Board and management, I want to thank Sherry for her contributions to Waters over the last four years. I am also personally grateful for her help during my transition into Waters. Our dedicated and talented finance team is extremely well positioned to continue transforming the business and delivering on our objectives. We wish Sherry all the best in her next role,” commented Dr. Udit Batra, President and Chief Executive Officer of Waters Corporation. “We are pleased to have a leader of Mike’s caliber to serve as interim CFO. Throughout his 16 years at Waters, Mike has developed a deep understanding of our business, strategy and financial goals. The Board and I have the utmost confidence in Mike’s ability to focus on continued execution.”

    Mr. Silveira joined Waters in 2004 as Assistant Corporate Controller. He was appointed Vice President & Corporate Controller in 2013, and, in 2018, gained increased responsibilities including oversight of treasury, tax and corporate financial planning and analysis. He is a Certified Public Accountant and has held several senior financial management positions with Astro-Med, Inc (nka AstroNova), Textron, Inc. and KPMG. Mr. Silveira received a B.S. in Accounting from Providence College.

    About Waters

    Waters Corporation (NYSE:WAT), the world's leading specialty measurement company, has pioneered chromatography, mass spectrometry, and thermal analysis innovations serving the life, materials, and food sciences for more than 60 years. With more than 7,000 employees worldwide, Waters operates directly in 35 countries, including 15 manufacturing facilities, and with products available in more than 100 countries.

    Cautionary Statement

    This release contains “forward-looking” statements regarding future results and events, including statements regarding Ms. Buck’s departure, the appointment of Mr. Silveira as interim chief financial officer and the process to find a permanent replacement for Ms. Buck. For this purpose, any statements that are not statements of historical fact may be deemed forward-looking statements. Without limiting the foregoing, the words “will,” “feels”, “believes”, “anticipates”, “plans”, “expects”, “intends”, “suggests”, “appears”, “estimates”, “projects”, and similar expressions, whether in the negative or affirmative, are intended to identify forward-looking statements. Actual future results and events may differ significantly from the results and events discussed in the forward-looking statements within this release for a variety of reasons, including the factors that are discussed in the sections entitled “Forward-Looking Statements” and “Risk Factors” of the Company’s annual report on Form 10-K for the year ended December 31, 2019 as filed with the Securities and Exchange Commission (“SEC”), as updated by the Company’s subsequent filings with the SEC. The forward-looking statements included in this release represent the Company’s estimates or views as of the date of this release and should not be relied upon as representing the Company’s estimates or views as of any date subsequent to the date of this release. Except as required by law, the Company does not assume any obligation to update any forward-looking statements.

    Get the next $WAT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $WAT
    $TXT

    CompanyDatePrice TargetRatingAnalyst
    Waters Corporation
    $WAT
    6/2/2026$425.00Outperform
    Wolfe Research
    Textron Inc.
    $TXT
    4/30/2026Hold → Buy
    TD Cowen
    Waters Corporation
    $WAT
    4/6/2026$350.00In-line → Outperform
    Evercore ISI
    Textron Inc.
    $TXT
    4/1/2026$92.00Equal Weight
    Wells Fargo
    Waters Corporation
    $WAT
    2/10/2026$360.00In-line
    Evercore ISI
    Waters Corporation
    $WAT
    2/10/2026$425.00Buy
    Citigroup
    Waters Corporation
    $WAT
    2/10/2026$400.00Overweight
    Barclays
    Waters Corporation
    $WAT
    1/6/2026$440.00Buy
    Guggenheim
    More analyst ratings

    $WAT
    $TXT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SVP & Chief Financial Officer Chaubal Amol covered exercise/tax liability with 239 shares, decreasing direct ownership by 3% to 7,623 units (SEC Form 4) to satisfy withholding obligation

    4 - WATERS CORP /DE/ (0001000697) (Issuer)

    5/14/26 4:55:54 PM ET
    $WAT
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Director Clark R Kerry sold $234,308 worth of shares (2,517 units at $93.09), decreasing direct ownership by 23% to 8,611 units (SEC Form 4)

    4 - TEXTRON INC (0000217346) (Issuer)

    5/7/26 4:18:23 PM ET
    $TXT
    Aerospace
    Industrials

    Director Zuber Maria T was granted 2,061 shares, increasing direct ownership by 11% to 20,558 units (SEC Form 4)

    4 - TEXTRON INC (0000217346) (Issuer)

    5/1/26 4:13:35 PM ET
    $TXT
    Aerospace
    Industrials

    $WAT
    $TXT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Wolfe Research resumed coverage on Waters with a new price target

    Wolfe Research resumed coverage of Waters with a rating of Outperform and set a new price target of $425.00

    6/2/26 8:40:09 AM ET
    $WAT
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Textron upgraded by TD Cowen

    TD Cowen upgraded Textron from Hold to Buy

    4/30/26 3:08:40 PM ET
    $TXT
    Aerospace
    Industrials

    Waters upgraded by Evercore ISI with a new price target

    Evercore ISI upgraded Waters from In-line to Outperform and set a new price target of $350.00

    4/6/26 8:29:42 AM ET
    $WAT
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $WAT
    $TXT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Waters Announces FDA 510(k) Clearance of BD BACTEC FXI Culture System, Enabling Broader Access to Bloodstream Infection Diagnostics

    FDA 510(k)-cleared BD BACTEC™ FXI Culture System now available to U.S. market, enabling broader access to confident bloodstream infection diagnostics.Achieves a 3-hour faster time to detection (~15% reduction) versus the prior-generation system, per clinical study data, enabling earlier targeted sepsis prevention.Fully automated solution delivers an industry-leading 50% increase in vial loading and up to 960-vial per module capacity, maximizing walk-away time.MILFORD, Mass., June 3, 2026 /CNW/ -- Waters Corporation (NYSE:WAT) today announced that the BD BACTEC FXI Culture System has received U.S. Food and Drug Administration (FDA) 510(k) clearance. This clearance enables commercialization in

    6/3/26 8:00:00 AM ET
    $WAT
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Waters Introduces Unrivaled Sensitivity and Speed to Benchtop HRMS with Xevo MRT P10 MS, Accelerating Multiomics Research

    Delivers up to 20x improvement in MS/MS sensitivity and 2x faster acquisition speeds, enabling deeper biological insight for next-generation multiomics, therapeutic, and high-throughput workflows.Identifies up to 40% more lipids by LC‑MS/MS than the leading alternative benchtop high‑resolution mass spectrometer, advancing lipidomics research and disease understanding.Sets a new benchmark for throughput in high-resolution spatial analysis with the DESI XS source, supporting higher-confidence studies of disease and treatment response.MILFORD, Mass., June 1, 2026 /CNW/ -- 74th ASMS Conference on Mass Spectrometry and Allied Topics—Waters Corporation (NYSE:WAT) today introduced the Waters Xevo™

    6/1/26 8:00:00 AM ET
    $WAT
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Waters Unveils Cyclic IMS P20 MS: The New Benchmark in Structural and Spatial Omics

    >10x step-change in MS/MS sensitivity paired with multipass Cyclic™ Ion Mobility Spectrometry (IMS) reveals subtle biological differences for earlier, previously unattainable detection of disease signals.50% extended upper mass range and comprehensive suite of structural tools advance the development of next-generation biotherapeutics.Integrated MALDI XS and DESI XS imaging with high-resolution ion mobility enables direct visualization of molecules in tissue, improving understanding of how disease develops at the cellular level.MILFORD, Mass., June 1, 2026 /PRNewswire/ -- 74th ASMS Conference on Mass Spectrometry and Allied Topics— Waters Corporation (NYSE:WAT) today announced the launch of

    6/1/26 8:00:00 AM ET
    $WAT
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $WAT
    $TXT
    SEC Filings

    View All

    SEC Form SD filed by Waters Corporation

    SD - WATERS CORP /DE/ (0001000697) (Filer)

    5/29/26 4:15:28 PM ET
    $WAT
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form SD filed by Textron Inc.

    SD - TEXTRON INC (0000217346) (Filer)

    5/29/26 4:05:30 PM ET
    $TXT
    Aerospace
    Industrials

    SEC Form 8-K filed by Waters Corporation

    8-K - WATERS CORP /DE/ (0001000697) (Filer)

    5/22/26 4:15:20 PM ET
    $WAT
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $WAT
    $TXT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Kennedy Thomas A bought $988,594 worth of shares (10,300 units at $95.98) and was granted 2,061 shares, increasing direct ownership by 158% to 20,162 units (SEC Form 4)

    4 - TEXTRON INC (0000217346) (Issuer)

    5/1/26 4:10:08 PM ET
    $TXT
    Aerospace
    Industrials

    Director Fearon Richard H bought $306,340 worth of shares (1,000 units at $306.34), increasing direct ownership by 43% to 3,302 units (SEC Form 4)

    4 - WATERS CORP /DE/ (0001000697) (Issuer)

    3/10/26 4:21:34 PM ET
    $WAT
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Fearon Richard H bought $332,900 worth of shares (1,000 units at $332.90), increasing direct ownership by 153% to 1,653 units (SEC Form 4)

    4 - WATERS CORP /DE/ (0001000697) (Issuer)

    5/29/24 11:23:35 AM ET
    $WAT
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $WAT
    $TXT
    Leadership Updates

    Live Leadership Updates

    View All

    Textron Aviation Launches Donation Campaign to Support 2026 Special Olympics Airlift; Continues Nationwide Call for Volunteer Doves

    Textron Aviation Inc., a Textron Inc. (NYSE:TXT) company, today announced the launch of a donation campaign benefitting Special Olympics in support of the 2026 Special Olympics Airlift, a nationwide effort that brings athletes and coaches to the Special Olympics USA Games through the generosity of volunteer pilots, aircraft owners and operators known as Doves. Financial contributions go directly to the Special Olympics, a 501(c)(3) charitable organization. New for the 2026 event, the donation campaign serves a vital role in ensuring each delegation has what it needs for a smooth and welcoming travel experience. This press release features multimedia. View the full release here: https://www

    3/2/26 11:00:00 AM ET
    $TXT
    Aerospace
    Industrials

    Omani and Jeanie Carson Named Inaugural Departure Day Dove 1 for 2026 Special Olympics Airlift, Donating Aircraft and Crew to Lead Athletes Home

    Textron Aviation Inc., a Textron Inc. (NYSE:TXT) company, today announced that Omani and Jeanie Carson, of Omaha, Nebraska, have been named the inaugural departure day Dove 1 for the 2026 Special Olympics Airlift. The Carsons will donate their aircraft and crew to lead athletes home at the conclusion of the Games, marking the first year this honorary departure day distinction has been established. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260226250477/en/Omani and Jeanie Carson named inaugural departure day Dove 1 for 2026 Special Olympics Airlift, donating aircraft and crew to lead athletes home (Photo credit: Textron Avia

    2/26/26 11:00:00 AM ET
    $TXT
    Aerospace
    Industrials

    Waters Completes Combination with BD's Biosciences & Diagnostic Solutions Businesses

    Announces appointment of Claire M. Fraser, Ph.D., to its Board of DirectorsForms a global life sciences and diagnostics leader focused on high-volume testing in regulated applicationsAnnounces formation of four divisions: Waters Analytical Sciences, Waters Biosciences, Waters Advanced Diagnostics, and Waters Materials SciencesMILFORD, Mass., Feb. 9, 2026 /PRNewswire/ -- Waters Corporation (NYSE:WAT) ("Waters") today announced it has completed the previously announced combination with the Biosciences & Diagnostic Solutions businesses of Becton, Dickinson and Company (NYSE:BDX) ("BD"). The transaction forms a global life sciences and diagnostics leader, equipped with best-in-class technologies

    2/9/26 8:40:00 AM ET
    $BDX
    $WAT
    Medical/Dental Instruments
    Health Care
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $WAT
    $TXT
    Financials

    Live finance-specific insights

    View All

    Waters Corporation (NYSE: WAT) Reports First Quarter 2026 Financial Results

    First Quarter 2026 HighlightsTotal reported revenue of $1.267 billion exceeded the high end of the guidance range by $56 million, driven by strong outperformance in both organic revenue and the acquired businesses.Organic revenue grew 13% as reported and 11% in constant currency, exceeding the high end of the constant currency growth guidance range by 200 basis points – led by high-single-digit instrument growth and mid-teens chemistry growth within the Analytical Sciences Division.The Biosciences and Diagnostic Solutions businesses generated $520 million of reported revenue since the closing of the acquisition – $40 million above guidance – driven by traction from commercial execution and o

    5/5/26 6:00:00 AM ET
    $WAT
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Textron Reports First Quarter 2026 Results; Announces Intent to Separate its Industrial Segment

    Revenues of $3.7 billion, up 12%, or $389 million, compared to the prior year EPS of $1.25; adjusted EPS of $1.45, up from $1.28 in the prior year Strong commercial order activity at Textron Aviation and Bell Textron to become a pure-play Aerospace & Defense platform aligned to its core franchises of Textron Aviation, Bell, and Textron Systems Textron Inc. (NYSE:TXT) today reported first quarter 2026 net income of $1.25 per share, compared to $1.13 in the first quarter of 2025. Adjusted net income, a non-GAAP measure that is defined and reconciled to GAAP in an attachment to this release, was $1.45 per share for the first quarter of 2026, compared to $1.28 per share in the firs

    4/30/26 6:30:00 AM ET
    $TXT
    Aerospace
    Industrials

    Textron Announces Intent to Separate its Industrial Segment, Enhancing Strategic Focus as a Pure-Play Aerospace and Defense Company

    Textron to become a pure-play Aerospace & Defense company aligned to its core franchises of Textron Aviation, Bell, and Textron Systems ("New Textron") Separation of Textron's Industrial segment – composed of Kautex and Textron Specialized Vehicles ("Industrial") Separation designed to enhance strategic focus and unlock shareholder value Textron Inc. (the "Company" or "Textron") (NYSE:TXT) today announced its intent to separate its Industrial segment from the Company's core aerospace and defense businesses to enhance its strategic and operational focus and drive long-term value for stakeholders. Textron intends to explore multiple paths to effect the planned separation of its Industrial

    4/30/26 6:30:00 AM ET
    $TXT
    Aerospace
    Industrials

    $WAT
    $TXT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Textron Inc.

    SC 13G/A - TEXTRON INC (0000217346) (Subject)

    11/14/24 1:28:29 PM ET
    $TXT
    Aerospace
    Industrials

    Amendment: SEC Form SC 13G/A filed by Waters Corporation

    SC 13G/A - WATERS CORP /DE/ (0001000697) (Subject)

    11/12/24 11:54:03 AM ET
    $WAT
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form SC 13G/A filed by Textron Inc. (Amendment)

    SC 13G/A - TEXTRON INC (0000217346) (Subject)

    2/14/24 10:04:34 AM ET
    $TXT
    Aerospace
    Industrials